Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ischemic Heart Disease

Free Subscription 04.05.2026 3 Am Heart J 9 Am J Cardiol 2 Angiology 1 Ann Thorac Surg 1 Can J Cardiol 1 Cardiovasc Res 1 Catheter Cardiovasc Interv 2 Circ Cardiovasc Imaging 2 Circ Cardiovasc Interv 1 Circ J 1 Circulation 4 Clin Cardiol 1 Eur Heart J 3 Heart 5 Int J Cardiol 8 J Am Coll Cardiol 1 J Mol Cell Cardiol 7 Lancet 1 Mayo Clin Proc 1 PLoS Comput Biol 1 Thromb Haemost

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. WOELDERS ECI, Yosofi B, Peeters DAM, von Birgelen C, et al
   Short-term outcomes of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction; a randomized pilot study.
   Am Heart J. 2026 Apr 28:107460. doi: 10.1016/j.ahj.2026.107460.
   PubMed         Abstract available
   
   
2. JANSSEN S, Luijkx JJP, Swinnen W, Vriesendorp P, et al
   Direct oral anticoagulation interruption versus continuation in patients undergoing elective invasive coronary angiography or percutaneous coronary intervention: design and rationale of the South Limburg Myocardial Infarction study group trial 2 (SLIM
   Am Heart J. 2026 Apr 27:107462. doi: 10.1016/j.ahj.2026.107462.
   PubMed         Abstract available
   
   
3. LIU OC, Billings J, Katz JN, Rao SV, et al
   Association Between Hospital Ownership Type and ST-Segment Elevation Myocardial Infarction Outcomes: Insights from the National Readmission Database, 2016-2022.
   Am Heart J. 2026 Apr 23:107452. doi: 10.1016/j.ahj.2026.107452.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

4. LEE JV, Emmanuela M, Patricio A, Theja DA, et al
   Side Branch Protection in Coronary Bifurcation Stenting: A Systematic Review and Meta-Analysis of Jailed Wire Versus Jailed Balloon Technique.
   Am J Cardiol. 2026;267:58-67.
   PubMed         Abstract available
   
   
5. TIOTSOP M, Salabei JK
   Integrating Anatomy and Ischemia in Chest Pain Evaluation.
   Am J Cardiol. 2026;267:93-96.
   PubMed         Abstract available
   
   
6. KUMAR S, Trenschel R, Mishra T, Yasumura K, et al
   Cracking Coronary Calcium With Intravascular Lithotripsy: A Review.
   Am J Cardiol. 2026;267:120-133.
   PubMed         Abstract available
   
   
7. ANIGBOGU C, Cotton JL, Su Y, Reece TB, et al
   Ten-Year All-Cause Mortality Following CABG: A Sex-Stratified Analysis of Revascularization.
   Am J Cardiol. 2026;267:44-50.
   PubMed         Abstract available
   
   
8. ALFONSO F, Shaburishvili T, Farah B, Gogorishvili I, et al
   Three-Year Clinical Follow-Up of a Novel Everolimus-Coated Balloon for Patients With In-Stent Restenosis.
   Am J Cardiol. 2026;267:39-43.
   PubMed         Abstract available
   
   
9. VADLAKONDA U, Frueh B, Khan M, Reed M, et al
   Patient Outcomes From Home-Based Virtual Cardiac Rehabilitation Within a Large Integrated Healthcare System.
   Am J Cardiol. 2026;267:15-20.
   PubMed         Abstract available
   
   
10. GURGOGLIONE FL, Vlieger S, Cheng JM, Heang TM, et al
    Paclitaxel versus sirolimus-coated balloons for coronary artery disease: 2-year follow-up of two large registries.
    Am J Cardiol. 2026 Apr 27:S0002-9149(26)00310.
    PubMed         Abstract available
    
    
11. WOJCIECH W, Ullah I, Gurgoglione FL, Iwanczyk S, et al
    Comparison of percutaneous Intervention with dRug Coated balloons and drug Eluting stents for de novo coronary artery disease: CIRCE, a systematic review and meta-analysis.
    Am J Cardiol. 2026 Apr 25:S0002-9149(26)00226.
    PubMed         Abstract available
    
    
12. KANE JA, Gilchrist I, Kalogeropoulos A, Al-Sadawi M, et al
    A Comparison of Three Commonly Used Catheter Strategies in Diagnostic Trans-radial Coronary Angiography.
    Am J Cardiol. 2026 Apr 22:S0002-9149(26)00240.
    PubMed         Abstract available
    
    

    
    Angiology

13. ENGIN M, Guler G, Demirci H
    Letter: Coronary Artery Disease and Carotid Artery Disease Are the Most Important Predictors of Major Adverse Cardiovascular Events.
    Angiology. 2026 Apr 27:33197261447328. doi: 10.1177/00033197261447328.
    PubMed        
    
    
14. SU Y, Li Y
    Effect of Invasive Hemodynamic Monitoring on the Outcomes of Cardiogenic Shock in Patients With Acute Myocardial Infarction.
    Angiology. 2026 Apr 27:33197261443814. doi: 10.1177/00033197261443814.
    PubMed        
    
    

    
    Ann Thorac Surg

15. ALARAJ R, Koprivanac MJ, Alshneikat M, Awad AK, et al
    Extended Zone Right Internal Thoracic Artery Coronary Artery Bypass Grafting.
    Ann Thorac Surg. 2026 Apr 25:S0003-4975(26)00408.
    PubMed         Abstract available
    
    

    
    Can J Cardiol

16. KAVSAK PA, Pickering JW, Strauss B, Greenslade JH, et al
    External validation of a universal laboratory pathway for early risk-stratification of myocardial infarction in the emergency setting.
    Can J Cardiol. 2026 Apr 28:S0828-282X(26)00380.
    PubMed        
    
    

    
    Cardiovasc Res

17. PALA L, Torres-Lopez M, Caldwell ST, Valadares J, et al
    Mitochondrial succinate transport is required for cardiac ischaemia/reperfusion injury.
    Cardiovasc Res. 2026;122:734-747.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

18. WATANABE S, Onuma J, Ishida R, Masuda R, et al
    Clinical Significance of V4R ST-Segment Elevation on a Synthesized 18-Lead Electrocardiogram in Patients With Anterior ST-Segment Elevation Myocardial Infarction.
    Catheter Cardiovasc Interv. 2026 Apr 26. doi: 10.1002/ccd.70646.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Imaging

19. DHARMAKUMAR R, Vora K
    Hemorrhagic Myocardial Infarction: Who Is at Risk?
    Circ Cardiovasc Imaging. 2026 Apr 29:e019900.
    PubMed        
    
    
20. SCHINDLER TH, Okzan E
    Integrating PET-Determined Global and Focal Impairment of Myocardial Flow Reserve to Enhance Cardiovascular Prognostication?
    Circ Cardiovasc Imaging. 2026 May 1:e019868. doi: 10.1161/CIRCIMAGING.126.019868
    PubMed        
    
    

    
    Circ Cardiovasc Interv

21. OHASHI H, Kuramitsu S, Ando H, Shinozaki T, et al
    Prognostic Impact of Renal Function on Outcomes After Physiology-Guided Coronary Revascularization: Insights From the J-PRIDE Registry.
    Circ Cardiovasc Interv. 2026 Apr 27:e016454.
    PubMed         Abstract available
    
    
22. FISCHER Q, Nault I, Cepas-Guillen P, Avvedimento M, et al
    Systematic Ambulatory ECG Monitoring for Preventing Life-Threatening Cardiovascular Events Following TAVR.
    Circ Cardiovasc Interv. 2026 Apr 30:e016288.
    PubMed         Abstract available
    
    

    
    Circ J

23. HIGA S, Sakanashi M, Tsutsui M, Tasaki T, et al
    Two Faces of Cardiovascular Actions of Testosterone Dependent on the Presence or Absence of Nitric Oxide Synthases in Mice.
    Circ J. 2026;90:549-558.
    PubMed         Abstract available
    
    

    
    Circulation

24. ZHU K, Guo J, Liu Y, Li J, et al
    TRIM28 Is an E3 Ligase of IRP2 Suppressing Ischemia/Reperfusion-Induced Myocardial Ferroptosis.
    Circulation. 2026;153:1314-1336.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

25. WEI J, Ji T, Yuan Y, Liu S, et al
    The Correlations and Predictive Capabilities of the "Life's Essential 8" With Respect to All-Cause Mortality and Cardiovascular Disease Mortality Risks in Individuals Experiencing Sleep Disorders: A Prospective Cohort Study From the NHANES (2005-2014)
    Clin Cardiol. 2026;49:e70336.
    PubMed         Abstract available
    
    
26. HABIB A, Khan MSM, Aneeq A, Tahir HMT, et al
    Apolipoprotein A-I (CSL112) and Cardiovascular Outcomes in Atherosclerotic Cardiovascular Disease: A Scoping Review.
    Clin Cardiol. 2026;49:e70305.
    PubMed         Abstract available
    
    
27. RUAN Z, Tu J, Xu H, Zhi Y, et al
    Plasma EDA2R and Risk of Cardiovascular Diseases and All-Cause Mortality: Analysis of the UK Biobank Cohort.
    Clin Cardiol. 2026;49:e70314.
    PubMed         Abstract available
    
    
28. LI ZJ, Li BG
    Note for Male Smokers: The Healthy Eating Index Associated With the Risk of Subclinical Myocardial Injury.
    Clin Cardiol. 2026;49:e70330.
    PubMed         Abstract available
    
    

    
    Eur Heart J

29. KRONBORG AH, Hasselbalch RB, Pedersen CHG, Knudsen SS, et al
    Macrotroponin I: association with suspected myocardial infarction with non-obstructive coronary artery.
    Eur Heart J. 2026 Apr 28:ehag312. doi: 10.1093.
    PubMed        
    
    

    
    Heart

30. ZHOU AL, Chinedozi ID, Holmes SD, Gammie JS, et al
    Safety of internal thoracic artery use in patients with prior mediastinal radiation undergoing coronary artery bypass grafting: a Maryland statewide propensity-matched analysis.
    Heart. 2025 Aug 18:heartjnl-2025-325949. doi: 10.1136/heartjnl-2025-325949.
    PubMed         Abstract available
    
    
31. KAWCZYNSKI MJ, Barili F MD PhD FESC, Brophy JM, De Caterina R, et al
    Revascularisation strategies for non-acute myocardial ischaemic syndromes.
    Heart. 2025 Sep 14:heartjnl-2025-326101. doi: 10.1136/heartjnl-2025-326101.
    PubMed         Abstract available
    
    
32. ORTEGA-PAZ L, Laudani C, Brugaletta S, Vidal-Cales P, et al
    Derivation and validation of a prediction model for long-term mortality in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the PREDICT-ST-Elevation Myocardial Infarction score.
    Heart. 2026 Apr 29:heartjnl-2026-327811. doi: 10.1136/heartjnl-2026-327811.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

33. FREENE N, Seymour J, McPhail SM, Tyack Z, et al
    Frequency of a very brief intervention to increase physical activity levels in cardiac rehabilitation attendees: The 'Measure It!' Multicentre randomised trial.
    Int J Cardiol. 2026;455:134480.
    PubMed         Abstract available
    
    
34. WU JY, Lee KW, Huang SC, Chang HY, et al
    Association between Ranolazine use and outcomes in patients with suspected MINOCA: A propensity-matched cohort study.
    Int J Cardiol. 2026;455:134504.
    PubMed         Abstract available
    
    
35. BO K, Qu T, Wang H, Yue X, et al
    Deep learning-based non-contrast cine CMR for optimized prediction of left ventricular adverse remodeling after ST-elevation myocardial infarction.
    Int J Cardiol. 2026 Apr 22:134499. doi: 10.1016/j.ijcard.2026.134499.
    PubMed         Abstract available
    
    
36. AYAYO SA, Mamas MA
    Evolving epidemiology and improving outcomes in acute myocardial infarction: Lessons from 25 years of population-level data.
    Int J Cardiol. 2026;456:134511.
    PubMed        
    
    
37. POLLER A, Jha S, Thorleifsson SJ, Espinosa AS, et al
    Left ventricular diastolic function over the acute and subacute phase in the Takotsubo syndrome versus ST-elevation myocardial infarction.
    Int J Cardiol. 2026;456:134522.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

38. BATCHELOR WB, Califf R, Mehran R, Stone G, et al
    Aligning Coronary Stent Trial Enrollment With the U.S. Intended-Use Population: Implications of Site Selection.
    J Am Coll Cardiol. 2026;87:2163-2176.
    PubMed         Abstract available
    
    
39. LEE JM, Kim O, Song YB, Lee JY, et al
    Intravascular Imaging- vs Angiography-Guided Complex PCI: 5-Year Outcomes From a Randomized Trial.
    J Am Coll Cardiol. 2026 Mar 4:S0735-1097(26)00147.
    PubMed         Abstract available
    
    
40. HLATKY MA, Ding VY, Zimmermann FM, Piroth Z, et al
    Economic Outcomes and Quality of Life After CABG or PCI for Multivessel Disease: The FAME 3 Trial.
    J Am Coll Cardiol. 2026;87:2147-2159.
    PubMed         Abstract available
    
    
41. QUINN R, Petek BJ, Churchill TW, Moulson N, et al
    Clinical Documentation of an Individualized Emergency Action Plan for Young Athletes With Cardiovascular Conditions at Risk for Sudden Cardiac Arrest.
    J Am Coll Cardiol. 2026 Apr 29:S0735-1097(26)05796.
    PubMed        
    
    
42. MISRA A, Jowell A, Haidermota S, Perez E, et al
    Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular Conditions.
    J Am Coll Cardiol. 2026 Apr 29:S0735-1097(26)05809.
    PubMed         Abstract available
    
    
43. VALLE JA, Megaly M, Manandhar P, Rymer JA, et al
    Contemporary Trends in Percutaneous Coronary Intervention at Facilities Without On-Site Cardiac Surgery: Insights From the National Cardiovascular Data Registry.
    J Am Coll Cardiol. 2026;87:2193-2195.
    PubMed        
    
    
44. BLANKENSHIP JC, Ponce-Orellana C
    A Step Toward Diversity and Inclusion in Cardiovascular Research Trials.
    J Am Coll Cardiol. 2026;87:2177-2179.
    PubMed        
    
    
45. COUGHLAN JJ, Colleran R
    Novel Bioresorbable Scaffold for the Treatment of Patients With Coronary Artery Disease: Could the Holy Grail Be Made of Iron?
    J Am Coll Cardiol. 2026;87:2131-2133.
    PubMed        
    
    

    
    J Mol Cell Cardiol

46. DHALLA NS, Patel CA, Beladiya JV, Mehta AA, et al
    Pathophysiology and pharmacotherapy of cardiovascular complications in metabolic syndrome.
    J Mol Cell Cardiol. 2026 Apr 23:S0022-2828(26)00058.
    PubMed         Abstract available
    
    

    
    Lancet

47. ZENG G, Bidel Z, Yang Q, Canoy D, et al
    Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis.
    Lancet. 2026;407:1626-1638.
    PubMed         Abstract available
    
    
48. MANGALESH S, Theodoropoulos P, Chi KY, Nanna MG, et al
    Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial.
    Lancet. 2026;407:1601.
    PubMed        
    
    
49. TONDT J, Chinchilli VM
    Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial.
    Lancet. 2026;407:1601.
    PubMed        
    
    
50. DEANFIELD J, Emerson SS, Rasmussen S, Stensen S, et al
    Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial - Authors' reply.
    Lancet. 2026;407:1601-1602.
    PubMed        
    
    
51. SUN Y, Guo X
    Cardiovascular benefit of blood-pressure lowering in chronic kidney disease.
    Lancet. 2026;407:1578-1580.
    PubMed        
    
    
52. FROBERT O, Pedersen IB, Hjelholt AJ, Erikstrup C, et al
    Off-target benefits of influenza vaccination in cardiovascular disease.
    Lancet. 2026;407:1599-1600.
    PubMed        
    
    
53. DU X, Anderson CS
    Off-target benefits of influenza vaccination in cardiovascular disease - Authors' reply.
    Lancet. 2026;407:1600.
    PubMed        
    
    

    
    Mayo Clin Proc

54. DI VENANZIO L, Pinna A, Hamidabad NM, Copley EA, et al
    Traditional Risk Factors Provide Limited Insight Into Long-Term Cardiovascular Risk After Carotid Endarterectomy.
    Mayo Clin Proc. 2026 Apr 22:S0025-6196(26)18488.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

55. ROSALES RM, Rios-Munoz GR, Nava AMS, Fernandez-Santos ME, et al
    In silico assessment of arrhythmic risk following the implantation of engineered heart tissues in porcine hearts with varying infarct locations.
    PLoS Comput Biol. 2026;22:e1013740.
    PubMed         Abstract available
    
    

    
    Thromb Haemost

56. SCHOENHERR A, Ji Y, Khoukaz H, Lyu Z, et al
    Plasminogen Activator Inhibitor-1 Controls Mitochondrial Oxidative Stress in Vascular Smooth Muscle Cells and Coronary Arteries.
    Thromb Haemost. 2026 Apr 24. doi: 10.1055/a-2852-0770.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum